Cardax

Cardax Net Change in Cash

The Net Change in Cash of Cardax (CDXI) as of Oct 19, 2026 is -100.00 USD. In the previous year, Net Change in Cash was -224,500.00 USD — a change of -99.96% (higher).

Net Change in Cash

-100.00USD

YoY

-99.96%

Last updated:

Net Change in Cash of Cardax is 2020 -100.00 USD. Net Change in Cash of Cardax was 2019 -224,500.00 USD. It decreases by -99.96% higher compared to the previous year.

The Cardax Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2015
287,700.00 USD
Jan 1, 2016
-165,000.00 USD
Jan 1, 2017
2.08 M USD
Jan 1, 2018
-1.99 M USD
Jan 1, 2019
-224,500.00 USD
Jan 1, 2020
-100.00 USD
The Cardax Net Change in Cash history
YEARNet Change in CashYoY
-100.00USD-99.96%
-224,500.00USD-88.74%
-1.99 MUSD-195.90%
2.08 MUSD-1,359.64%
-165,000.00USD-157.35%
287,700.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cardax Stock analysis

What does Cardax do? Cardax Inc, a development stage biopharmaceutical company based in Honolulu, Hawaii, focuses on developing pharmaceuticals for chronic diseases driven by inflammation. The company has 10 full-time employees and went public via an IPO on January 30, 2012. Cardax is currently developing two pre-clinical pharmaceutical candidates: CDX-101 and CDX-301. CDX-101 is a proprietary astaxanthin prodrug designed to deliver astaxanthin to the bloodstream following oral administration. Astaxanthin is a naturally occurring molecule known for its anti-inflammatory properties, supporting cardiovascular health, metabolic health, liver health, joint health, and longevity. CDX-301 is a pharmaceutical candidate for macular degeneration, utilizing zeaxanthin, which accumulates in the human eye through a retinal receptor to protect against blue light, oxidative damage, and inflammation associated with macular degeneration. The company's headquarters are located in Honolulu, and it operates within the Health Care sector, specifically in the Pharmaceuticals industry. Cardax Inc's website is https://cardaxpharma.com/. The company is seeking to monetize its pre-clinical candidates, CDX-101 and CDX-301, as it advances its development pipeline. No additional details about the company's financials, specific acquisition history, or other product names are provided in the available information. Cardax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cardax stock

Net Change in Cash of Cardax is -100.00 USD in 2020.

Net Change in Cash of Cardax changed from -224,500.00 USD to -100.00 USD, representing a -99.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Cardax since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Cardax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cardax

All Key Metrics — Cardax